Science

MOTS-c: The Mitochondrial Peptide Studied for Metabolic Health and Exercise Performance

Scientists discovered MOTS-c hiding in mitochondrial DNA in 2015. Sixteen amino acids that nobody knew existed, controlling metabolism and exercise adaptation. It declines with age. We can't legally prescribe it. Yet.

What Is MOTS-c?

MOTS-c stands for "Mitochondrial Open Reading Frame of the 12S rRNA-c." Scientists love acronyms.

It's 16 amino acids long and encoded by mitochondrial DNA - not nuclear DNA like most proteins. For decades, researchers thought that stretch of mitochondrial DNA was junk. Turns out it was coding for a metabolic regulator the whole time.

USC researchers discovered it in 2015. Changhan David Lee and Pinchas Cohen realized mitochondria weren't just cellular power plants - they were sending out peptide signals to control metabolism.

MOTS-c can work inside mitochondria or translocate to the nucleus. When metabolic stress hits (exercise, fasting, cold exposure), MOTS-c heads to the nucleus and starts changing gene expression. Dual-location peptide, dual function.

The longevity angle? MOTS-c levels decline with age. Plus, there's a genetic variant (m.1382A>C) in some populations associated with exceptional longevity. Coincidence? Researchers don't think so.

How Does MOTS-c Work?

How MOTS-c works - the mechanisms:

AMPK activation: AMPK is your cellular fuel gauge. When it's activated, your cells get better at producing energy and using fuel efficiently. MOTS-c flips this switch, triggering glucose uptake, fat oxidation, and mitochondrial biogenesis.

Metabolic cycle regulation: MOTS-c tweaks the folate and methionine cycles - biochemical pathways critical for methylation, DNA synthesis, and antioxidant production. Better stress response, better cellular maintenance.

Stress-triggered nuclear signaling: This is wild. When you exercise or restrict calories, MOTS-c moves from mitochondria to the nucleus and starts changing gene expression. It coordinates mitochondrial and nuclear responses to energy demands.

Insulin sensitivity boost: Animal studies show MOTS-c improves how muscle cells respond to insulin and take up glucose. That matters for metabolic health and fighting age-related insulin resistance.

Mitochondrial protection: MOTS-c appears to keep mitochondria healthy and efficient as they age. Better energy production, less dysfunction.

What Is MOTS-c Studied For?

What researchers are studying MOTS-c for:

Reality check: preclinical research looks fantastic. Human studies? Barely started.

Most evidence comes from petri dishes and rodents. Whether this translates to actual human benefits remains an open question.

Availability Notice: MOTS-c is currently classified as Category 2 under FDA regulations, meaning it is not currently available for prescription through compounding pharmacies. Category 2 substances are under review and may become available in the future pending regulatory evaluation. This article is for educational purposes only.

Regulatory Status

MOTS-c is Category 2. Not available for prescription through U.S. compounding pharmacies.

What does Category 2 mean? The FDA is reviewing it. They're looking at safety data, clinical need, and whether approved alternatives exist. The timeline? Variable. Could be months. Could be years. Could be never.

Why the regulatory limbo? MOTS-c was only discovered in 2015. Human data is thin. The FDA wants substantial safety and efficacy evidence before allowing widespread compounding. Preclinical excitement doesn't cut it.

PeptidePrescript only offers Category 1 peptides. We track regulatory updates, but MOTS-c isn't available through us.

If you're interested in MOTS-c, know this:

Side Effects and Safety

Most current safety data on MOTS-c comes from preclinical research, with the human evidence base continuing to develop.

Animal studies: Well-tolerated at studied doses. No major adverse effects reported. But animal data doesn't equal human safety.

Long-term unknowns: What happens if you use MOTS-c for years? Does it affect cancer risk? Immune function? Other systems? Nobody knows. These questions need proper clinical trials.

Injection risks: MOTS-c would be injected - subcutaneous or intramuscular. Standard injection risks apply: site reactions, infection if technique is sloppy, possible allergic reactions.

Genetic variability: Some people naturally have a MOTS-c variant (m.1382A>C) associated with longevity. Genetic differences might mean different responses to supplemental MOTS-c. One size won't fit all.

Why Category 2? The FDA wants real human safety data before allowing widespread use. Makes sense when you're dealing with a peptide discovered less than a decade ago.

If MOTS-c becomes available for compounding, it would be accessed through medical supervision and accredited 503A pharmacies, not unregulated sources.

Key Takeaway: MOTS-c is a mitochondrial-derived peptide with promising preclinical research supporting its potential roles in metabolic regulation, exercise performance, and healthy aging. However, it is currently not available for prescription use in the United States due to its Category 2 regulatory status. Human clinical data is limited, and safety in humans has not been established through proper trials.

Frequently Asked Questions

When will MOTS-c be available?

There is currently no definitive timeline for when or if MOTS-c will become available for prescription use through compounding pharmacies. The FDA's review process for Category 2 substances is ongoing and depends on the submission of additional safety and clinical data by interested parties. Changes to regulatory status could occur within months or could take years, depending on the evidence presented and FDA priorities.

How is MOTS-c different from other mitochondrial peptides?

MOTS-c is one of several mitochondrial-derived peptides (MDPs) that have been discovered in recent years. Unlike humanin and other MDPs, MOTS-c is specifically encoded by the 12S rRNA gene and has distinct metabolic regulatory functions focused on AMPK activation and exercise adaptation. Each MDP appears to have specialized roles in cellular signaling and metabolic regulation.

Can I use MOTS-c for athletic performance enhancement?

MOTS-c is not currently available for any use, including athletic performance enhancement. Additionally, athletes should be aware that MOTS-c would likely be considered a prohibited substance under World Anti-Doping Agency (WADA) regulations due to its potential performance-enhancing effects and peptide hormone classification.

Is MOTS-c the same as taking mitochondrial supplements?

No. MOTS-c is a specific peptide with direct signaling and regulatory functions, while common "mitochondrial supplements" like CoQ10, PQQ, or NAD+ precursors work through different mechanisms. MOTS-c functions as a signaling molecule that regulates metabolic gene expression and enzyme activity, which is fundamentally different from providing substrate or cofactors for mitochondrial metabolism.

Are there natural ways to increase MOTS-c?

Research suggests that exercise, particularly endurance exercise, may naturally increase MOTS-c levels or enhance its signaling. Metabolic stress and caloric restriction have also been shown to increase MOTS-c expression in animal models. However, research into natural modulation of MOTS-c is still in early stages, and specific recommendations cannot be made based on current evidence.

Scientific References

  1. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. Lee C et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell metabolism. 2015.
  2. Reynolds JC, Lai RW, Woodhead JST, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat Commun. 2021;12(1):470. Reynolds JC et al. "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis." Nature communications. 2021.
  3. Kim KH, Son JM, Benayoun BA, Lee C. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab. 2018;28(3):516-524.e7. Mangalhara KC et al. "A Mitochondrial-Derived Peptide Exercises the Nuclear Option." Cell metabolism. 2018.
  4. Lu H, Tang S, Xue C, et al. Mitochondrial-Derived Peptide MOTS-c Increases Adipose Thermogenic Activation to Promote Cold Adaptation. Int J Mol Sci. 2019;20(10):2456. Lu H et al. "Mitochondrial-Derived Peptide MOTS-c Increases Adipose Thermogenic Activation to Promote Cold Adaptation." International journal of molecular sciences. 2019.
  5. Fuku N, Pareja-Galeano H, Zaporozhchenko V, et al. The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity? Aging Cell. 2015;14(6):921-923. Fuku N et al. "The mitochondrial-derived peptide MOTS-c: a player in exceptional longevity?." Aging cell. 2015.

MOTS-C Isn't Available Yet - Join the Waitlist to Be Notified

MOTS-C is Category 2 and not currently available for compounding in the United States. PeptidePrescript monitors FDA guidance daily and will notify waitlist subscribers the moment MOTS-C's status changes.

View the catalog Join the Waitlist

Not ready for the waitlist? Get weekly peptide research and FDA updates delivered to your inbox.

Free weekly newsletter. Unsubscribe anytime.